Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum

Karolina Andrzejczyk,Sabrina Abou Kamar,Anne-Mar van Ommen,Elisa Dal Canto,Teun B Petersen,Gideon Valstar,K Martijn Akkerhuis,Maarten Jan Cramer,Victor Umans,Frans H Rutten,Arco Teske,Eric Boersma,Roxana Menken,Bas M van Dalen,Leonard Hofstra,Marianne Verhaar,Jasper Brugts,Folkert Asselbergs,Hester den Ruijter,Isabella Kardys

DOI: https://doi.org/10.1038/s41598-024-65667-0

2024-06-27

Abstract:Circulating proteins may provide insights into the varying biological mechanisms involved in heart failure (HF) with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). We aimed to identify specific proteomic patterns for HF, by comparing proteomic profiles across the ejection fraction spectrum. We investigated 4210 circulating proteins in 739 patients with normal (Stage A/Healthy) or elevated (Stage B) filling pressures, HFpEF, or ischemic HFrEF (iHFrEF). We found 2122 differentially expressed proteins between iHFrEF-Stage A/Healthy, 1462 between iHFrEF-HFpEF and 52 between HFpEF-Stage A/Healthy. Of these 52 proteins, 50 were also found in iHFrEF vs. Stage A/Healthy, leaving SLITRK6 and NELL2 expressed in lower levels only in HFpEF. Moreover, 108 proteins, linked to regulation of cell fate commitment, differed only between iHFrEF-HFpEF. Proteomics across the HF spectrum reveals overlap in differentially expressed proteins compared to stage A/Healthy. Multiple proteins are unique for distinguishing iHFrEF from HFpEF, supporting the capacity of proteomics to discern between these conditions.